# SCEMBLIX
> **NDA215358** · New Drug Application · Sponsor: NOVARTIS · Approved 2021-10-29
## Drug
- **FDA Application Number:** NDA215358
- **Application type:** New Drug Application
- **Brand name:** SCEMBLIX
- **Generic name:** ASCIMINIB
- **Active ingredients:** ASCIMINIB HYDROCHLORIDE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** NOVARTIS
- **Manufacturer:** Novartis Pharmaceuticals Corporation
- **First approval:** 2021-10-29
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215358)
---
*AI Analytics · CC0 1.0*